Advertisement

Topics

Stentys SA STNT Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 20062018] Prices from USD $250

06:20 EDT 14 Sep 2018 | BioPortfolio Reports

Summary


Stentys SA Stentys is a medical device company that designs, develops and markets selfexpanding stents for the treatment of patients with acute myocardial infarction and coronary disease. The company's products include BMS and DES stents, self apposing coronary stent systems, SES stents; selfapposing bare metal stents and drug eluting stent, and aspiration catheter stents, among others. Its self apposing drugeluting stents are designed to adapt to vessels with ambiguous or fluctuating diameters to prevent the malapposition problems associated with conventional stents. Stentys conducts clinical program to demonstrate the safety and efficacy of its products. The company has operations in Germany, France, Italy, the Netherlands, Scandinavia, Poland, Spain and Switzerland. Stentys is headquartered in Paris, France.


Stentys SA STNT Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions.


GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research.


Scope


Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector.

Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios.

Business Description A brief description of the company's operations.

Key Employees A list of the key executives of the company.

Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors A list of the key competitors of the company.

Key Recent Developments A brief on recent news about the company.


Reasons to Buy


Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.


Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.


Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.


Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.


Stay uptodate on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.


Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.


Note*: Some sections may be missing if data is unavailable for the company.

Original Article: Stentys SA STNT Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 20062018] Prices from USD $250

NEXT ARTICLE

More From BioPortfolio on "Stentys SA STNT Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 20062018] Prices from USD $250"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Medical Devices
The role of medical devices in healthcare is essential.  The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare.  Covering a wide range of products, from simple bandages to the...

Acute Coronary Syndromes ACS
Acute Coronary Syndromes (ACS) is an umbrella term for situations where the blood supplied to the heart muscle is suddenly blocked. Treatment for acute coronary syndrome includes medicines and a procedure known as angioplasty, during which doctors inflat...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...